| 000 | 01732 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515000648.0 | ||
| 264 | 0 | _c20071206 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a1360-8185 | ||
| 024 | 7 |
_a10.1007/s10495-005-2942-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDrexler, H C A | |
| 245 | 0 | 0 |
_aSynergistic apoptosis induction by proteasome and histone deacetylase inhibitors is dependent on protein synthesis. _h[electronic resource] |
| 260 |
_bApoptosis : an international journal on programmed cell death _cAug 2005 |
||
| 300 |
_a743-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBH3 Interacting Domain Death Agonist Protein _xmetabolism |
| 650 | 0 | 4 |
_aButyrates _xpharmacology |
| 650 | 0 | 4 |
_aCaspase 8 _xmetabolism |
| 650 | 0 | 4 |
_aCycloheximide _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xmetabolism |
| 650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 | _aProteasome Inhibitors |
| 650 | 0 | 4 |
_aProtein Biosynthesis _xdrug effects |
| 650 | 0 | 4 | _aU937 Cells |
| 650 | 0 | 4 | _aVorinostat |
| 650 | 0 | 4 |
_afas Receptor _xmetabolism |
| 700 | 1 | _aEuler, M | |
| 773 | 0 |
_tApoptosis : an international journal on programmed cell death _gvol. 10 _gno. 4 _gp. 743-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10495-005-2942-4 _zAvailable from publisher's website |
| 999 |
_c15769868 _d15769868 |
||